We used immunocompetent mice as a preclinical model to address the involvement of ARHGEF17 in tumorigenesis by syngeneic LAP0297 lung cancer cells and established the mechanism by which Gi-coupled LPARs activate this RhoGEF. This evidence concerns the gene ARHGEF17 and lung carcinoma.